x
Visit our new Mobile Website next time you access NetDania with your mobile device

BIOXCEL THERAPEUTICS INC. - COMMON STOCK

2.09
10-19:59:56 GMT
-0.22
-9.33%
ISIN:N/A

Figures - BIOXCEL THERAPEUTICS INC. - COMMON STOCK

Open
2.32
Close
2.30
Year Change
-29.15
Year % Change
-29.15%
52 Week High
28.46
52 Week Low
1.91
Volume
696007
Inc. Vol
17177

News - BIOXCEL THERAPEUTICS INC. - COMMON STOCK

13-11:46 GMT
Systems Of Intelligence: The Next Era Of CPG Value Chain Optimization And Decision-Making
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:46 GMT
Exploring New Frontiers: The Adoption Of Large Language Models In Banks
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:46 GMT
JPMorgan And Citigroup: Undervalued Giants Poised For Market-Beating Returns
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:46 GMT
Navigating The Future Of Attribution: Beyond Third-Party Cookies
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:46 GMT
Know Your Sources: AI-Driven Research Results Can Be Sketchy, So Dig Deeper
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:43 GMT
Retail Earnings And Latest Inflation Data From The CPI
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:41 GMT
Exploring Three Scenarios For How Gen AI Will Change Consumer Finance
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:40 GMT
Don't ignore the threat to the loonie that's lurking across the pond, economist warns
Source: FinancialPost-TopStories, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:32 GMT
Father’s Day Gift Guide 2024: Best Golf Gifts For The Golfing Dad
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:32 GMT
Four Tools For A Healthier Relationship With Stress
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:32 GMT
How Much Should Parents Contribute To College?
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:32 GMT
Citigroup Stock Has Gained 23% YTD, Where Is It Headed?
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:32 GMT
Patient-Centric Marketing For Therapists In The Digital Age
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:32 GMT
Pay Attention If You Want People's Attention
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:32 GMT
Taking The Restaurant Industry Mobile In 2024
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:32 GMT
Three Elements For Ensuring An Effective AI Strategy
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:32 GMT
Market Freedoms And National Security: Navigating US Economic Policy In A Globalized World
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
Add Up The Parts: XLV Could Be Worth $160
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
VOT's Underlying Holdings Imply 10% Gain Potential
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
Look Under The Hood: PBUS Has 10% Upside
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
How The Pieces Add Up: VONE Headed For $261
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
Analysts Expect 10% Gains Ahead For The Holdings of IYY
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
Analysts Forecast 14% Upside For IJS
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
Sum Up The Pieces: IJJ Could Be Worth $128
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
This S&P Metals & Mining Index Component Has A 1.4% Yield And Sells For Less Than Book
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
Union Pacific a Top 25 Dividend Giant With 2.10% Yield (UNP)
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
The Implied Analyst 12-Month Target For SKYY
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
VLO Named A Top Socially Responsible Dividend Stock
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
The Implied Analyst 12-Month Target For XSVM
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
Stocks Set to Open Higher as Investors Await U.S. Inflation Data and Retail Earnings, Fed Speak on Tap
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
Why Prosperity Bancshares is a Top 25 SAFE Dividend Stock (PB)
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:26 GMT
Analysts Expect FXD Will Reach $68
Source: NASDAQ Stocks, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:22 GMT
Why We Need Rapid Deployment Of Carbon Capture Technologies
Source: Forbes World, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:22 GMT
This S&P Metals & Mining Index Component Has A 1.4% Yield And Sells For Less Than Book
Source: NASDAQ US Markets, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:22 GMT
How The Pieces Add Up: VONE Headed For $261
Source: NASDAQ US Markets, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:22 GMT
Analysts Expect 10% Gains Ahead For The Holdings of IYY
Source: NASDAQ US Markets, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:22 GMT
Analysts Forecast 14% Upside For IJS
Source: NASDAQ US Markets, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:22 GMT
Sum Up The Pieces: IJJ Could Be Worth $128
Source: NASDAQ US Markets, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:21 GMT
IJR's Holdings Could Mean 12% Gain Potential
Source: NASDAQ US Markets, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
13-11:21 GMT
The Math Shows RPV Can Go To $94
Source: NASDAQ US Markets, Symbol: BIOXCEL THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
39584.96
103.62
0.26%
5237.82
18.68
0.36%
18232.33
80.44
0.44%
62758.00
1296
2.11%
18773.28
-28.68
-0.15%
38127.39
-92.28
-0.24%
3148.02
-6.53
-0.21%
8429.98
3.67
0.04%
19141.71
190.83
1.01%
7754.17
8.63
0.11%
22104.05
48.85
0.22%
2344.64
-14.98
-0.63%
83.26
0.585
0.71%
1.07933
0.00273
0.25%
155.855
0.165
0.11%
1.25491
0.00294
0.23%
0.66185
0.00204
0.31%
1.36721
0.00067
0.05%
168.22100
0.563
0.34%
0.86005
0.00089
0.10%
195.58300
0.697
0.36%
0.90593
0.00012
0.01%
0.97779
0.0022
0.23%
0.60213
0.00029
0.05%
105.21900
-0.087
-0.08%
Top Gainers
Name
Last
+/-
%
0.02
0.01
129.35%
2.58
1.38
115.00%
8.88
4.41
98.66%
0.01
0.00
63.89%
0.09
0.03
52.08%
0.02
0.01
50.00%
0.03
0.01
47.18%
17.44
5.25
43.07%
5.29
1.48
38.84%
0.11
0.03
36.25%
Top Losers
Name
Last
+/-
%
3.31
-11.36
-77.44%
0.01
-0.01
-51.20%
0.20
-0.15
-42.86%
2.36
-1.48
-38.54%
0.04
-0.03
-37.20%
0.04
-0.02
-36.24%
0.25
-0.14
-35.09%
0.58
-0.27
-32.04%
0.25
-0.11
-30.56%
0.00
0.00
-29.79%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy